
The associate professor from UC San Diego discussed promising efficacy and safety data from a phase 1/2 trial.

The associate professor from UC San Diego discussed promising efficacy and safety data from a phase 1/2 trial.

The associate professor from UC San Diego discussed the ongoing phase ½ trial of CTNS-RD

The associate professor from UC San Diego discussed the curative potential of gene therapy in cystinosis.

Published: February 14th 2022 | Updated: